Evidence against oppositional and pharmacokinetic mechanisms of tolerance to diazepam's sedative effects

Brain Research

Volumn 734, Issue 1-2, 1996, Pages 236-242

  Fernandes, Cathy ^a   File, Sandra E ^a   Berry, Dave ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b Medical Toxicology Unit   (United Kingdom)

Author keywords

Benzodiazepine; Exploration; Locomotor activity; Serum level; Tolerance; Withdrawal

Indexed keywords

DIAZEPAM; NORDAZEPAM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION;

EID: 0030599147     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00644-0     Document Type: Article

References (40)

1. [1] Freeman, H. and Rue, Y. (Eds.), The benzodiazepines in current clinical practice. In International Congress and Symposium Series, Royal Society of Medicine Services (London), Number 114, 1987.
2. [2] Eatman, F.B., Colburn, W.A., Boxenbaum, H.G., Postmanter, H.H., Wienfeld, R.W., Ronfeld, R., Weissman, L., Moore, J.D., Gibaldi, M. and Kaplan, S.A., Pharmacokinetics of diazepam following multiple dose oral administration in healthy human subjects, J. Pharmacokin. Biopharmacol., 5 (1977) 481-495.
3. [3] Ellinwood, E.H., Linnoila, M., Easler, M.E. and Molter, D.W., Profile of acute tolerance to three sedative anxiolytics, Psychopharmacology, 79 (1983) 137-141.
4. [4] File, S.E., Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats, Psychopharmacology, 73 (1981) 240-245.
5. [5] File, S.E., Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance, Psychopharmacology, 77 (1982) 284-288.
6. [6] File, S.E., Development and retention of tolerance to the sedative effects of chlordiazepoxide: role of apparatus cues, Eur. J. Pharmacol., 81 (1982) 637-643.
7. [7] File, S.E., Tolerance to the behavioural actions of benzodiazepines, Neurosci. Biobehav. Rev., 9 (1985) 113-122.
8. [8] File, S.E., The history of benzodiazepine dependence: a review of animal studies, Neurosci. Biobehav. Rev., 14 (1990) 135-146.
9. [9] File, S.E., The biological basis of anxiety. In H.Y. Meltzer and D. Nerozzi (Eds.), Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders, Excerpta Medica, Amsterdam, 1991, pp. 159-166.
10. [10] File, S.E., Biology of benzodiazepine action and dependence. In C. Hallstrom (Ed.), Benzodiazepine Dependence, Oxford University Press, 1993, pp. 95-118.
11. [11] File, S.E. and Baldwin, H.A., Changes in anxiety in rats tolerant to, and withdrawn from, benzodiazepines: behavioural and biochemical studies. In P. Tyrer (Ed.). Psychopharmacology of Anxiety, Oxford University Press, 1989, pp. 28-51.
12. [12] File, S.E. and Fernandes, C., Noise stress and the development of benzodiazepine dependence in the rat, Anxiety, 1 (1994) 8-12.
13. [13] File, S.E. and Wardill, A.G., Validity of head-dipping as a measure of exploration in a modified hole-board, Psychopharmacologia, 44 (1975) 53-59.
14. [14] File, S.E. and Wilks, L.J., Changes in seizure threshold and aggression during chronic treatment with three anticonvulsants and on drug withdrawal, Psychopharmacology, 100 (1990) 237-242.
15. [15] File, S.E. and Wilks, L.J., Effects of sodium phenobarbital on motor activity and exploration in the mouse: development of tolerance and incidence of withdrawal responses, Pharmacol. Biochem. Behav., 35 (1990) 317-320.
16. [16] File, S.E., Wilks, L.J. and Mabbutt, P.S., Withdrawal, tolerance and sensitization after a single dose of lorazepam, Pharmacol. Biochem. Behav., 31 (1989) 937-940.
17. [17] Gobbi, M., Barone, D., Mennini, T. and Garattini, S., Diazepam and desmethyldiazepam differ in their affinities and efficacies at 'central' and 'peripheral' benzodiazepine receptors, J. Pharm. Pharmacol., 39 (1987) 388-391.
18. [18] Goldberg, M.E., Manian, A. and Efron, D., A comparative study of certain pharmacologic responses following acute and chronic administration of chlordiazepoxide, Life Sci., 6 (1967) 481-491.
19. [19] Goudie, A.J., Behavioral techniques for assessing drug tolerance and sensitization. In A.A. Boulton, G.B. Baker and A.J. Greenshaw (Eds.), Neuromethods (Vol. 13) Psychopharmacology, Humana Press, New Jersey, 1989, pp. 565-622.
20. [20] Greeley, J. and Cappell, H., Associative control of tolerance to the sedative and hypothermic effects of chlordiazepoxide, Psychopharmacology, 86 (1985) 487-493.
21. [21] Greenblatt, D.J. and Shader, R.I., Benzodiazepines in Current Clinical Practice, Raven Press, New York, 1974.
22. [22] Greenblatt, D.J. and Shader, R.I., Long-term administration of benzodiazepines: pharmacokinetic versus pharmacodynamic tolerance, Psychopharmacol. Bull., 22 (1986) 416-423.
23. [23] Greenblatt, D.J. and Shader, R.I., Pharmacokinetics of antianxiety drugs. In H.Y. Meltzer (Ed.). Psychopharmacology: The Third Generation of Progress, Raven Press, New York, 1987, pp. 1377-1386.
24. [24] Griffiths, J.W. and Goudie, A.J., Analysis of the role of drug-predictive environmental stimuli in tolerance to the hypothermic effects of the benzodiazepine metabolism, Psychopharmacology, 90 (1986) 513-521.
25. [25] Higgitt, A., Fonagy, P. and Lader, M., The natural history of benzodiazepine dependence, Psychol. Med. Monogr., Suppl., 13 (1988) 1-55.
26. [26] Hoogland, D.R., Miya, T.S. and Bousquet, W.F., Metabolism and tolerance studies with chlordiazepoxide in the rat, Toxicol. Appl. Pharmacol., 9 (1966) 116-123.
27. [27] King, D.A., Bouton, M.A. and Musty, R.E., Associative control of tolerance to the sedative effect of a short acting benzodiazepine, Behav. Neurosci., 101 (1987) 104-114.
28. [28] Kunchandy, J. and Kulkarni, S.K., Reversal by α-2 agonists of diazepam withdrawal hyperactivity in rats, Psychopharmacology, 90 (1986) 198-202.
29. [29] Lader, M.H., The present status of benzodiazepines in psychiatry and medicine, Arzneim. Forsch., 30 (1980) 910-913.
30. [30] Linnoila, M., Kortila, K. and Mattila, M.J., Effect of food and repeated injections on serum diazepam levels, Acta Pharmacol. Toxicol., 36 (1975) 181-186.
31. [31] Lister, R.G., File, S.E. and Greenblatt, D.J., Functional tolerance to lorazepam in the rat, Psychopharmacology, 81 (1983) 292-294.
32. [32] Lucki, I. and Rickels, K., The behavioural effects of benzodiazepines following long-term use, Psychopharmacol. Bull., 22 (1986) 424-433.
33. [33] MacKenzie-Taylor, D.R. and Rech, R.H., Cellular and learned tolerances to chlordiazepoxide hypothermia and ataxia, Pharmacol. Biochem. Behav., 44 (1993) 717-725.
34. [34] Marcucci, F., Fanelli, E., Mussinei, E. and Garattini, S., Further studies on species difference in diazepam metabolism, Eur. J. Pharmacol., 9 (1970) 253-256.
35. [35] Rastogi, R.B., Lapierre, Y.D. and Singhal, R.L., Evidence for the role of brain norepinephrine and dopamine in 'rebound' phenomenon seen during withdrawal after repeated exposure to benzodiazepines, J. Psychiatr. Res., 13 (1976) 65-75.
36. [36] Rosenberg, H.C., Smith, S. and Chiu, T.H., Benzodiazepine - specific and nonspecific tolerance following chronic flurazepam treatment, Life Sci., 32 (1983) 279-285.
37. [37] Rutherford, D.M., Rapid micro-method for the measurement of diazepam and desmethyldiazepam in blood by gas-liquid chromatography, J. Chromatogr., 137 (1977) 439-448.
38. [38] Vorne, M.S., Puolakka, J.O. and Idanpaan-Keikkila, J.E., Diazepam, ethanol and drug metabolizing enzymes in rat liver, Arch. Int. Pharmacodyn. Ther., 216 (1975) 280-287.
39. [39] Woods, J.H., Katz, J.L. and Winger, G., Benzodiazepines: use, abuse and consequences, Pharmacol. Rev., 44 (1987) 151-347.
40. [40] Young, A.M. and Goudie, A.J., Adaptive processes regulating tolerance to behavioural effects of drugs. In. F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 733-742.